📊 CIRX Key Takeaways
Is Cirtran Corp. (CIRX) a Good Investment?
Cirtran Corp exhibits severe financial distress with negative stockholders' equity of -$25.5M, indicating the company is technically insolvent. The company is burning cash at an alarming rate with -$1.0M operating cash flow on just $1.1M revenue, while maintaining $27.5M in total liabilities that far exceed its $1.9M asset base. Revenue has contracted 19.8% YoY and the company is not generating sustainable operations.
CirTran Corp's fundamentals are severely impaired, with declining revenue, deeply negative operating and net margins, and free cash flow that is nearly as negative as revenue. The balance sheet is distressed, with negative equity, extremely weak liquidity, and liabilities that vastly exceed assets, indicating high financial risk and poor growth quality.
Why Buy Cirtran Corp. Stock? CIRX Key Strengths
- Maintains 49.5% gross margin, suggesting potential in product profitability if scaled efficiently
- Generated $533.1K in gross profit despite operational losses
- Minimal insider selling activity (0 Form 4 filings in last 90 days) shows limited confidence but no panic exits
- Gross margin remains relatively solid at 49.5%, suggesting the core product mix can still generate gross profit
- Asset base is still producing revenue, indicating the business has not fully collapsed operationally
- Capital expenditure is minimal, which limits additional cash drain from investment spending
CIRX Stock Risks: Cirtran Corp. Investment Risks
- Negative equity position of -$25.5M creates existential solvency risk and potential equity wipeout
- Critical liquidity crisis with current ratio of 0.07x and only $19.3K cash against $27.5M liabilities
- Severe operating cash burn of -$1.0M annually combined with declining revenue (-19.8% YoY) makes near-term survival questionable
- Negative interest coverage of -2.2x indicates inability to service debt obligations from operations
- Operating losses of -$403.0K and net losses of -$1.1M suggest business model is fundamentally broken
- Revenue declined 19.8% YoY, pointing to weak demand or deteriorating business momentum
- Liquidity is critical, with only $19.27K cash and a 0.07x current ratio
- Negative equity of $25.54M and total liabilities of $27.46M create substantial solvency and restructuring risk
Key Metrics to Watch
- Cash depletion rate and runway before insolvency
- Ability to refinance or restructure $27.5M liabilities
- Revenue trend reversal and path to positive operating cash flow
- Stockholders' equity recovery and deleveraging progress
- Operating cash flow and ending cash balance
- Revenue trend and current liability reduction
Cirtran Corp. (CIRX) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CIRX Profit Margin, ROE & Profitability Analysis
CIRX vs Consumer Sector: How Cirtran Corp. Compares
How Cirtran Corp. compares to Consumer sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cirtran Corp. Stock Overvalued? CIRX Valuation Analysis 2026
Based on fundamental analysis, Cirtran Corp. has mixed fundamental signals relative to the Consumer sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cirtran Corp. Balance Sheet: CIRX Debt, Cash & Liquidity
CIRX Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Cirtran Corp.'s revenue has shown modest growth of 7% over the 5-year period. The most recent EPS of $-0.53 indicates the company is currently unprofitable.
CIRX Revenue Growth, EPS Growth & YoY Performance
CIRX Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $256.1K | -$155.4K | $-0.09 |
| Q2 2025 | $168.4K | -$155.4K | $-0.08 |
| Q1 2025 | $429.4K | -$155.4K | $-0.03 |
| Q3 2024 | $256.1K | -$205.8K | $-0.04 |
| Q2 2024 | $390.5K | -$243.0K | $-0.05 |
| Q1 2024 | $213.4K | -$480.3K | $-0.10 |
| Q3 2023 | $477.0K | -$205.8K | $-0.04 |
| Q2 2023 | $458.5K | -$243.0K | $-0.05 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Cirtran Corp. Dividends, Buybacks & Capital Allocation
CIRX SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cirtran Corp. (CIK: 0000813716)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CIRX
What is the AI rating for CIRX?
Cirtran Corp. (CIRX) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 96% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CIRX's key strengths?
Claude: Maintains 49.5% gross margin, suggesting potential in product profitability if scaled efficiently. Generated $533.1K in gross profit despite operational losses. ChatGPT: Gross margin remains relatively solid at 49.5%, suggesting the core product mix can still generate gross profit. Asset base is still producing revenue, indicating the business has not fully collapsed operationally.
What are the risks of investing in CIRX?
Claude: Negative equity position of -$25.5M creates existential solvency risk and potential equity wipeout. Critical liquidity crisis with current ratio of 0.07x and only $19.3K cash against $27.5M liabilities. ChatGPT: Revenue declined 19.8% YoY, pointing to weak demand or deteriorating business momentum. Liquidity is critical, with only $19.27K cash and a 0.07x current ratio.
What is CIRX's revenue and growth?
Cirtran Corp. reported revenue of $1.1M.
Does CIRX pay dividends?
Cirtran Corp. does not currently pay dividends.
Where can I find CIRX SEC filings?
Official SEC filings for Cirtran Corp. (CIK: 0000813716) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CIRX's EPS?
Cirtran Corp. has a diluted EPS of $-0.23.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CIRX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Cirtran Corp. has a STRONG SELL rating with 96% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CIRX stock overvalued or undervalued?
Valuation metrics for CIRX: ROE of N/A (sector avg: 18%), net margin of -105.6% (sector avg: 8%). Compare these metrics with sector averages to assess valuation.
Should I buy CIRX stock in 2026?
Our dual AI analysis gives Cirtran Corp. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CIRX's free cash flow?
Cirtran Corp.'s operating cash flow is $-1.0M, with capital expenditures of $8.4K. FCF margin is -96.5%.
How does CIRX compare to other Consumer stocks?
Vs Consumer sector averages: Net margin -105.6% (avg: 8%), ROE N/A (avg: 18%), current ratio 0.07 (avg: 1.5).